Sacituzumab Tirumotecan and Toripalimab in the First-line Treatment of HNSCC

Clinical trial NCT07088211 · RECRUITING

Trial details

NCT number: NCT07088211
Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Start date: 2025-07-29
Primary completion: 2027-08-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.